ATE346607T1 - Verfahren und zusammensetzungen zur inhibition der angiogenese - Google Patents

Verfahren und zusammensetzungen zur inhibition der angiogenese

Info

Publication number
ATE346607T1
ATE346607T1 AT01968398T AT01968398T ATE346607T1 AT E346607 T1 ATE346607 T1 AT E346607T1 AT 01968398 T AT01968398 T AT 01968398T AT 01968398 T AT01968398 T AT 01968398T AT E346607 T1 ATE346607 T1 AT E346607T1
Authority
AT
Austria
Prior art keywords
methods
compounds
angiogenesis
inhibition
compositions
Prior art date
Application number
AT01968398T
Other languages
English (en)
Inventor
Mahesh C Sharma
George P Tuszynski
Original Assignee
Philadelphia Health & Educatio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philadelphia Health & Educatio filed Critical Philadelphia Health & Educatio
Application granted granted Critical
Publication of ATE346607T1 publication Critical patent/ATE346607T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01968398T 2000-09-01 2001-09-04 Verfahren und zusammensetzungen zur inhibition der angiogenese ATE346607T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22966700P 2000-09-01 2000-09-01
US27720401P 2001-03-20 2001-03-20

Publications (1)

Publication Number Publication Date
ATE346607T1 true ATE346607T1 (de) 2006-12-15

Family

ID=26923501

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01968398T ATE346607T1 (de) 2000-09-01 2001-09-04 Verfahren und zusammensetzungen zur inhibition der angiogenese

Country Status (9)

Country Link
EP (1) EP1313504B1 (de)
JP (1) JP2004507482A (de)
AT (1) ATE346607T1 (de)
AU (1) AU2001288648A1 (de)
CA (1) CA2421503A1 (de)
DE (1) DE60124927T2 (de)
DK (1) DK1313504T3 (de)
ES (1) ES2272537T3 (de)
WO (1) WO2002017857A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002044328A2 (en) 2000-11-28 2002-06-06 Waisman David M Anti-angiogenic polypeptides
AU2003297181A1 (en) 2002-12-13 2004-07-09 Mediomics, Llc Compositions and methods for inhibiting tumor growth and metastasis
EP1670510A1 (de) * 2003-09-24 2006-06-21 Peter Krammer Antikörper gegen annexine, ihre verwendung in der therapie und diagnose, verwendung von annexinen für therapie und diagnose
DE102004046540A1 (de) * 2004-09-21 2006-04-06 Eberhard-Karls-Universität Tübingen Universitätsklinikum Annexin-Modulation und Infektionsresistenz
US20060111423A1 (en) * 2004-10-26 2006-05-25 Zeligs Michael A Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus-associated disease
WO2012048190A1 (en) 2010-10-08 2012-04-12 Regents Of The University Of Minnesota Annexin ii compositions and methods
DK3068428T3 (da) * 2013-11-13 2022-10-17 Univ Minnesota Annexin-ii-variant-sammensætninger og fremgangsmåder
EP3045470A1 (de) 2015-01-15 2016-07-20 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Modulatoren der Funktion der Kerndomäne von Annexinen und Verwendungen davon in der Autoimmun- und/oder Krebstherapie
PT3468621T (pt) 2016-06-10 2022-12-21 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts O domínio central das anexinas e suas utilizações no fornecimento e vacinação de antigénios

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051364A (en) * 1989-02-16 1991-09-24 The Salk Institute For Biological Studies Anti-lipocortin-I and anti-lipocortin-II monoclonal antibodies
US5639725A (en) * 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
US5945403A (en) * 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
AU3455599A (en) * 1998-03-27 1999-10-18 Board Of Trustees Of The Leland Stanford Junior University Hypoxia-inducible human genes, proteins, and uses thereof
BR9913331A (pt) * 1998-08-25 2001-05-15 Lexigen Pharm Corp Expressão e exportação de inibidores de angiogênese como imunofusinas

Also Published As

Publication number Publication date
EP1313504A4 (de) 2004-06-30
EP1313504B1 (de) 2006-11-29
DE60124927T2 (de) 2007-09-20
AU2001288648A1 (en) 2002-03-13
JP2004507482A (ja) 2004-03-11
WO2002017857A2 (en) 2002-03-07
DK1313504T3 (da) 2007-02-26
EP1313504A2 (de) 2003-05-28
WO2002017857A3 (en) 2002-06-13
DE60124927D1 (de) 2007-01-11
ES2272537T3 (es) 2007-05-01
CA2421503A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
BG101841A (bg) Инхибитори на клетъчна адхезия
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
SI1509232T1 (sl) Kombinacija antagonista nmda in zaviralcev acetilholinesteraze za zdravljenje alzheimerjeve bolezni
DE60014873D1 (de) Synergistische zusammensetzungen zur krebsbehandlung
BR0008922A (pt) Compostos úteis como agentes antiinflamatórios
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
MY134783A (en) Rho-kinase inhibitors
MY142915A (en) Rho-kinase inhibitors
PT1187918E (pt) Antagonistas de tek
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
NO20003018D0 (no) Triazinangiogenese-inhibitorer
DE69841984D1 (de) Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
ATE346607T1 (de) Verfahren und zusammensetzungen zur inhibition der angiogenese
BRPI0411864A (pt) combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas
ATE469907T1 (de) Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen
WO2002018341A8 (en) Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
EE200200632A (et) Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
DE60214388D1 (de) Verbindungen, bei denen es sich um wirksame inhibitoren des na+/ca2+ austauschmechanismus handelt und die sich zur behandlung von arrhythmien eignen
DK1185293T3 (da) IL6RIL6-kimær til behandling af neurodegenerative sygdomme
ATE374197T1 (de) Indolderivate zur behandlung von erkrankungen des zentralnervensystems
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1313504

Country of ref document: EP

REN Ceased due to non-payment of the annual fee